Early Tobacco Abstinence - 5
This trial has been terminated.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|End date||October 2004|
|Trial size||140 participants|
|Trial identifier||NCT00224965, NIDA-13334-5, P50-13334-5|
This proposal will conduct a prospective examination of the clinical course (intensity, content and duration) of tobacco (nicotine) abstinence effects in male and female smokers who are either heavy/light alcohol drinkers with/without depressive symptoms.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
Male or female participants from 18 years up to 60 years old.
- Current dependence on cocaine, marijuana, opiates or alcohol
- Positive urine screen for marijuana, cocaine or opiates at any appointment after the intake appointment.
- Regular use of any psychoactive drugs including anxiolytics and antidepressants;
- Current major depression or other psychiatric conditions
- Subjects with any significant, untreated current medical conditions condition such as neurological, endocrine, cardiovascular, renal, liver, thyroid pathology or on medications for any recent medical events 6) Pregnant or lactating women -
|Official title||Early Tobacco Abstinence in High Risk Smokers|
|Principal investigator||Stephanie O'Malley, Ph.D.|
|Description||1. To compare male and female smokers, with and without current depressive symptoms, in a prospective study of the intensity, content & duration of nicotine abstinence effects during an eight-day abstinence period, and responses to cue exposure (invivo cigarette cues, alcohol and negative affect-inducing imagery cues) during acute vs. prolonged abstinence and, 2. To compare male and female smokers, who are either heavy alcohol drinkers or light alcohol drinkers, in a prospective study of the intensity, content & duration of nicotine abstinence effects during an eight-day abstinence period, and responses to cue exposure (invivo cigarette cues, alcohol and negative affect-inducing imagery cues) during acute vs. prolonged abstinence.|
Call for more information